Dawn Svoronos
CIK 1574579 · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.62M
Companies
7
Total Filings
58
Lifetime Open-Market Net
-$1.28M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XENE | Director | 27,645 | $52.10 | $1.44M | -$826.7K | 13 | 2026-06-03 |
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Director | 0 | $4.36 | $0 | $225.9K | 9 | 2025-12-10 |
| ACELYRIN, Inc. (SLRN) Delisted | Director | 15,000 | $2.27 | $34.0K | $270.0K | 2 | 2024-06-11 |
| Global Blood Therapeutics, Inc. (GBT) Delisted | Director | 0 | $68.49 | $0 | -$273.4K | 7 | 2022-10-06 |
| PTCT | Director | 29,017 | $75.14 | $2.18M | $235.8K | 12 | 2022-06-10 |
| ENDOCYTE INC (ECYT) Delisted | Director | 0 | — | — | $0 | 2 | 2018-12-21 |
| MEDIVATION, INC. (MDVN) Delisted | Director | 21,206 | — | — | -$910.9K | 10 | 2016-06-23 |
Recent Filings · Page 2 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-02 | XENE | Grant (A) | — | $0 | EDGAR |
| 2023-05-11 | ACELYRIN, Inc. (SLRN) Delisted | Mixed | +15,000 | $270.0K | EDGAR |
| 2023-05-04 | — | Grant (A) | — | $0 | |
| 2022-10-06 | Global Blood Therapeutics, Inc. (GBT) Delisted | Disp (D) | −5,376 | $0 | EDGAR |
| 2022-06-29 | XENE | Grant (A) | — | $0 | EDGAR |
| 2022-06-22 | Global Blood Therapeutics, Inc. (GBT) Delisted | Sell (S) | −1,908 | -$52.0K | EDGAR |
| 2022-06-16 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | +3,600 | $0 | EDGAR |
| 2022-06-14 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | PTCT | Sell (S) | −738 | -$20.1K | EDGAR |
| 2022-05-18 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Buy (P) | +30,000 | $25.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.